Related Experiment Video
Updated: Feb 27, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Parkinson Disease and Melanoma: Confirming and Reexamining an Association
Lauren A Dalvin1, Gena M Damento2, Barbara P Yawn3
1Department of Ophthalmology, Mayo Clinic, Rochester, MN.
Objective:
To examine an association between melanoma and Parkinson disease (PD).
Patients And Methods:
Phase I: Rochester Epidemiology Project records were used to identify (between January 1, 1976, and December 31, 2013) patients with PD in Olmsted County, Minnesota, with 3 matched controls per case. After review, JMP statistical software with logistic regression analysis was used to assess the risk of preexisting melanoma in patients with PD vs controls. Phase II: All Rochester Epidemiology Project cases of melanoma were identified (between January 1, 1976, and December 31, 2014), with 1 control per case. A Cox proportional hazards model was used to assess the risk of developing PD after the index date in cases vs controls, and Kaplan-Meier analysis was performed to determine the 35-year cumulative risk of PD. A Cox proportional hazards model was used to assess the risk of death from metastatic melanoma in patients with melanoma without PD compared with those with PD.
Results:
Phase I: Patients with PD had a 3.8-fold increased likelihood of having preexisting melanoma as compared with controls (95% CI, 2.1-6.8; P<.001). Phase II: Patients with melanoma had a 4.2-fold increased risk of developing PD (95% CI, 2.0-8.8; P<.001). Kaplan-Meier analysis revealed an increased 35-year cumulative risk of PD in patients with melanoma (11.8%) compared with controls (2.6%) (P<.001). Patients with melanoma without PD had a 10.5-fold increased relative risk of death from metastatic melanoma compared with patients with melanoma with PD (95% CI, 1.5-72.2) (P=.02).
Conclusion:
There appears to be an association between melanoma and PD. Further study is warranted; but on the basis of these results, physicians may consider counseling patients with melanoma about PD risk and implementing cutaneous and ocular melanoma surveillance in patients with PD.
Insights
People with Parkinson disease (PD) have a significantly higher risk of prior melanoma. Melanoma patients also show an increased risk of developing PD, suggesting a strong association.
Area of Science:
- Neurology
- Dermatology
- Epidemiology
Background:
- Parkinson disease (PD) is a neurodegenerative disorder.
- Melanoma is a type of skin cancer.
- The relationship between PD and melanoma requires further investigation.
Purpose of the Study:
- To investigate the association between melanoma and Parkinson disease (PD).
Main Methods:
- Phase I utilized Rochester Epidemiology Project records to assess preexisting melanoma in PD patients versus controls using logistic regression.
- Phase II evaluated the risk of developing PD in melanoma patients versus controls using Cox proportional hazards models and Kaplan-Meier analysis.
- The risk of death from metastatic melanoma in patients with and without PD was also assessed.
Main Results:
- Patients with PD had a 3.8-fold increased likelihood of preexisting melanoma.
- Melanoma patients demonstrated a 4.2-fold increased risk of developing PD.
- A 35-year cumulative risk of PD in melanoma patients was 11.8% compared to 2.6% in controls.
- Patients with melanoma without PD had a 10.5-fold increased relative risk of death from metastatic melanoma.
Conclusions:
- A significant association exists between melanoma and Parkinson disease.
- Physicians should consider counseling melanoma patients on PD risk.
- Cutaneous and ocular melanoma surveillance may be beneficial for PD patients.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Neural Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...

